First Time Loading...

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 31.4 CNY -0.03% Market Closed
Updated: Jun 1, 2024

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Long-Term Investments Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Long-Term Investments
¥9.6B
CAGR 3-Years
47%
CAGR 5-Years
32%
CAGR 10-Years
16%
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Long-Term Investments
¥4.7B
CAGR 3-Years
14%
CAGR 5-Years
39%
CAGR 10-Years
77%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Long-Term Investments
¥684.7m
CAGR 3-Years
189%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Long-Term Investments
¥645.6m
CAGR 3-Years
-14%
CAGR 5-Years
-9%
CAGR 10-Years
2%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Long-Term Investments
¥1.5B
CAGR 3-Years
-2%
CAGR 5-Years
72%
CAGR 10-Years
76%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Long-Term Investments
¥12.9B
CAGR 3-Years
107%
CAGR 5-Years
121%
CAGR 10-Years
68%

See Also

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Long-Term Investments?
Long-Term Investments
9.6B CNY

Based on the financial report for Mar 31, 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Long-Term Investments amounts to 9.6B CNY.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
16%

Over the last year, the Long-Term Investments growth was 45%. The average annual Long-Term Investments growth rates for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have been 47% over the past three years , 32% over the past five years , and 16% over the past ten years .